Share of 127-megawatt aggregated deal in collaboration with Eurofins Scientific will power over half of Thermo Fisher’s addressable European footprint with 100% renewable electricity by 2025.

Innovation provides United States with first workflow update in 25 years.

PhysioMimix NASH assay used to provide human-relevant data on compound efficacy for Inipharm’s lead candidate, INI-822.

New macro mass photometer can assess the stability, quality, and purity of adenovirus and lentivirus vectors in just minutes.

PlaqueTec announced that it has received the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approval to continue its BIOPATTERN trial following recruitment of the first ten patients with CAD.

AMSBIO announce the launch of a custom service providing access to a suite of powerful spatial biology multi-omics profiling tools.

Innovative, easy-to-use molecular diagnostics workflow reduces complexity and costs for labs looking to expand newborn screening capabilities.

Collaboration leverages expertise in artificial intelligence from Genentech and NVIDIA to unlock scientific innovation and empower R&D at a scale previously unattainable in pursuit of novel therapies.

Xybion Corporation is pleased to announce the acquisition of Autoscribe Informatics. This acquisition represents a significant strategic expansion in the Company’s Laboratory Information Management System (LIMS) business globally.

Yourgene’s LightBench® instrument offers precise and accurate size selection of PacBio® SMRTbell® sequencing libraries increasing HiFi sequencing yields.